The benefits of single-use systems for enhanced process security
Sep
4
2024
Upcoming webinar

The benefits of single-use systems for enhanced process security

Wednesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Sponsor
The benefits of single-use systems for enhanced process security

Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format.

As cell and gene therapy companies work to deliver life-changing results, production scale and sterility should remain a key priority. Without sterile connectors, users typically look to join tubing by either making connections under a laminar flow hood or via tube welding. Both are viable options, however, they have inherent disadvantages such as low efficiency, unreliable consistency, and high costs.

To address these disadvantages, converting to sterile connectors - specifically single-use connectors - can be considered. These connectors create fast, easy, and sterile connections for small fluid connections. In addition, sterile connectors eliminate the need for specialized tools and equipment, and create sterile connections even in non-sterile environments.

In this webinar, we will review the topics of process safeguarding, operator convenience, and true scalability solutions, in addition to presenting cost-benefit considerations.

Attend the webinar to:

  • Gain insights on single-use sterile connectors and how these address the challenges of joint tubing, specifically in both scale-up and scale-out processes
  • Understand the importance of small-volume transfer via sterile connectors in cell and gene therapy treatments due to the nature of precious genetic material
  • Discover how to enhance the process security of single-use connectors, ensuring process safeguarding, operator convenience, and cost benefits
Eoin Dolan
Eoin Dolan
Applications Development Manager, Cell & Gene Therapy at Colder Products Company

Eoin Dolan joined CPC as application development manager for CGT in August 2021. Eoin has fifteen years of engineering development and process improvement in various industries. The last decade of their career has been dedicated to the design and development of single-use solutions for various aspects of biopharmaceutical and ATMP (Advanced Therapy Medicinal Products).Eoin has a passion for developing fit-for-purpose solutions and driving efficiency through the implementation of single-use material to speed market access to cell and gene therapies.

in 9
Days

SPEAKERS

Eoin Dolan
Eoin Dolan
Applications Development Manager, Cell & Gene Therapy at Colder Products Company

You might also like